J. B. Chemicals & Pharmaceuticals Dirección
Dirección controles de criterios 2/4
El CEO de J. B. Chemicals & Pharmaceuticals es Nikhil Chopra , nombrado en Dec 2020, tiene una permanencia de 3.92 años. compensación anual total es ₹71.34M, compuesta por 49.2% salario y 50.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.026% de las acciones de la empresa, por valor de ₹69.90M. La antigüedad media del equipo directivo y de la junta directiva es de 1.8 años y 4.1 años, respectivamente.
Información clave
Nikhil Chopra
Chief Executive Officer (CEO)
₹71.3m
Compensación total
| Porcentaje del salario del CEO | 49.2% |
| Permanencia del CEO | 3.9yrs |
| Participación del CEO | 0.03% |
| Permanencia media de la dirección | 1.8yrs |
| Promedio de permanencia en la Junta Directiva | 4.1yrs |
Actualizaciones recientes de la dirección
Recent updates
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 27
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Nov 09J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price
Sep 24Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation
Aug 15J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 11These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Apr 19J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹6b |
| Jun 30 2024 | n/a | n/a | ₹6b |
| Mar 31 2024 | ₹71m | ₹35m | ₹6b |
| Dec 31 2023 | n/a | n/a | ₹5b |
| Sep 30 2023 | n/a | n/a | ₹5b |
| Jun 30 2023 | n/a | n/a | ₹4b |
| Mar 31 2023 | ₹65m | ₹37m | ₹4b |
| Dec 31 2022 | n/a | n/a | ₹4b |
| Sep 30 2022 | n/a | n/a | ₹4b |
| Jun 30 2022 | n/a | n/a | ₹4b |
| Mar 31 2022 | ₹59m | ₹18m | ₹4b |
| Dec 31 2021 | n/a | n/a | ₹4b |
| Sep 30 2021 | n/a | n/a | ₹5b |
| Jun 30 2021 | n/a | n/a | ₹4b |
| Mar 31 2021 | ₹32m | ₹7m | ₹4b |
Compensación vs. Mercado: La compensación total de Nikhil($USD846.14K) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD610.84K).
Compensación vs. Ingresos: La compensación de Nikhil ha sido consistente con los resultados de la empresa en el último año.
CEO
Nikhil Chopra (51 yo)
3.9yrs
Permanencia
₹71,338,000
Compensación
Mr. Nikhil Ashokkumar Chopra serves as Chief Executive Officer and Whole-Time Director at J. B. Chemicals & Pharmaceuticals Limited since December 23, 2020 and has been its Director since May 10, 2020. He...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Whole-Time Director | 3.9yrs | ₹71.34m | 0.026% ₹ 69.9m | |
| Assistant Vice President – Human Resource | no data | ₹10.48m | 0.0025% ₹ 6.7m | |
| Chief Financial Officer | less than a year | ₹12.74m | sin datos | |
| President of Operations | no data | ₹28.44m | sin datos | |
| Vice President of Finance & Accounts | no data | ₹9.48m | sin datos | |
| Vice President of Information & Technology | 9.8yrs | ₹10.70m | sin datos | |
| Vice President of HR & Administration | 8.2yrs | ₹13.80m | 0.00084% ₹ 2.3m | |
| Vice President of Legal | 1.8yrs | ₹11.49m | sin datos | |
| President of Global Business | no data | ₹42.09m | 0.012% ₹ 31.5m | |
| Executive Vice President of Operations of Daman | 1.3yrs | ₹17.24m | 0.0048% ₹ 13.1m | |
| Executive Vice President of Supply Chain Operations | no data | ₹19.54m | 0.0084% ₹ 22.7m | |
| Executive Vice President | less than a year | ₹18.12m | 0.0032% ₹ 8.7m |
1.8yrs
Permanencia media
51yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de JBCHEPHARM no se considera experimentado ( 1.8 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Whole-Time Director | 4.1yrs | ₹71.34m | 0.026% ₹ 69.9m | |
| Chairman of Biotech Laboratories (Pty ) Ltd | no data | sin datos | sin datos | |
| Non-Executive Independent Chairman | less than a year | sin datos | sin datos | |
| Non-Executive & Independent Director | 4.3yrs | ₹7.50m | sin datos | |
| Non-Executive Director | 4.3yrs | sin datos | sin datos | |
| Non-Executive & Non-Independent Director | less than a year | sin datos | sin datos | |
| Non-Executive Director | 3.8yrs | sin datos | sin datos | |
| Non-Executive & Independent Director | 4.3yrs | ₹7.50m | sin datos |
4.1yrs
Permanencia media
64.5yo
Promedio de edad
Junta con experiencia: La junta directiva de JBCHEPHARM se considera experimentada (4.1 años de antigüedad promedio).